Real life experience with ceftolozane/tazobactam therapy for Pseudomonas aeruginosa bacteremia
Autor: | Vincent H. Tam, Kady Phe, Sumaira Khan |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
medicine.medical_specialty Urinary system 030106 microbiology medicine.disease_cause Tazobactam 03 medical and health sciences 0302 clinical medicine Internal medicine polycyclic compounds medicine Pharmacology (medical) Pharmacology Pseudomonas aeruginosa business.industry CEFTOLOZANE/TAZOBACTAM biochemical phenomena metabolism and nutrition medicine.disease Pneumonia Infectious Diseases Oncology 030220 oncology & carcinogenesis Bacteremia Ceftolozane business medicine.drug |
Zdroj: | Journal of Chemotherapy. 33:595-597 |
ISSN: | 1973-9478 1120-009X |
Popis: | Ceftolozane/tazobactam is a β-lactam/β-lactamase inhibitor combination indicated for complicated urinary tract/intra-abdominal infections and pneumonia. Although promising in-vitro activity has bee... |
Databáze: | OpenAIRE |
Externí odkaz: |